Should You Buy This Sinking Stock on the Dip?

The biotech isn't having the best year.There are things that can affect and sink the stock prices of companies in most industries. One of them is a short-seller report. Axsome Therapeutics (AXSM -1.34%), a mid-cap biotech, was recently the target of one, and it already wasn't having a great year on the stock market. Though it might be tempting for investors sitting on the sidelines to purchase the drugmaker's shares while they are failing to keep pace with the bull market, some might argue that it would be ...